Table 5 Effect size of TG/HDL-C on baPWV in prespecified and exploratory subgroups
Characteristic | No of participants | Effect size(95%CI) | P for interaction |
|---|---|---|---|
Age (year) | 0.85 | ||
≤60 | 139 | 6.0 (− 12.3, 24.3) | |
> 60 | 773 | 4.1 (− 3.8, 12.0) | |
Sex | 0.69 | ||
Male | 592 | 3.2 (−4.8, 11.2) | |
Female | 320 | 7.2 (−11.4, 25.8) 8.0 (− 10.5, 26.5)a | |
Current smoking | 0.15 | ||
No | 715 | 7.4 (−1.2, 16.0) | |
Yes | 197 | −4.0 (−17.1, 9.1) | |
Ex-Smoking | |||
No | 462 | 8.6 (−4.0, 21.2) | 0.31 |
Yes | 450 | 0.8 (−8.1, 9.8) | |
Regular Exercise (> 1 week) | 0.67 | ||
No | 719 | 4.6 (−3.3, 12.5) | |
Yes | 177 | 0.08 (−20.1, 20.2) | |
Fatty liver | 0.99 | ||
No | 646 | 7.3 (− 2.4, 17.0) | |
Yes | 265 | 7.4 (−4.3, 19.1) | |
Alcohol consumption | 0.01 | ||
≤40 (g/week) | 581 | 7.1 (−2.9, 17.0) | |
40–140 | 150 | 7.0 (−11.3, 25.3) | |
140–280 | 88 | −5.2 (−25.4, 15.0) | |
> 280 | 80 | −30.7 (−53.1, −8.4) | |
BMI | 0.50 | ||
< 18.5 | 36 | 51.9 (−33.8, 137.6) | |
> = 18.5, < 23 | 435 | 5.2 (−6.5, 16.9) | |
> = 23 | 441 | 2.8 (−6.5, 12.2) | |
Hypertension | 0.72 | ||
No | 790 | 4.4 (−3.6, 12.3) | |
Yes | 122 | 8.4 (−12.3, 29.0) | |
Uric acid (tertile) | 0.07 | ||
Low | 298 | −6.0 (−25.4, 13.3) | |
Middle | 308 | 14.7 (1.3, 28.1) | |
High | 306 | −2.8 (−13.0, 7.3) | |